Crossmark

Meta-analysis of pharmacogenetic clinical decision support systems for the treatment of major depressive disorder

Published Online: 2022-10-22

Published Print: 2023-05

Authors

Skryabin, Valentin https://orcid.org/0000-0002-4942-8556
Rozochkin, Ilya

Zastrozhin, Mikhail

Lauschke, Volker

Franck, Johan

Bryun, Evgeny

Sychev, Dmitry
License Information

Text and Data Mining valid from 2022-10-22

Version of Record valid from 2022-10-22
More Information

Article History

Received: 6 September 2022

Revised: 6 October 2022

Accepted: 10 October 2022

First Online: 22 October 2022

Competing interests

: VML is co is CEO and shareholder of HepaPredict AB, co-founder and shareholder of PersoMedix AB and discloses consultancy work for Enginzyme AB.

Document is current